Cardiovascular Health across the Lifespan (CHAL) Program

The Cardiovascular Health across the Lifespan (CHAL) Program includes fundamental , clinical and evaluative research platforms. Basic research in this program focuses on the study of biomarkers, histopathology, genetics, translational genomics and genetic epidemiology. Biomedical and clinical research is conducted in the domains of biodesign, health technology, regenerative medicine and information technology, with observational cardiovascular studies and clinical trials completed or underway. CHAL investigators with expertise in epidemiology conduct population health, outcomes and health services research.

The CHAL Program is primarily located at the Glen site of the Research Institute of the McGill University Health Centre (RI‑MUHC), with several of its members at the Montreal General Hospital of the MUHC site. CHAL investigators perform research at the Centre for Translational Biology, the Centre for Innovative Medicine and the Centre for Health Outcomes Research at the RI‑MUHC.

The Cardiovascular Health across the Lifespan Program (CHAL) Program is centered around three main research themes:

• Vascular Health
• Cardiac Health
• Complex heart health

Review our selected high-impact publications in the 2024 RI-MUHC Annual Report.

More selections:  2023; 2022; 2021; 2020.

Explore the CHAL Program

News and Events

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

News

The CHAL Program organizes and supports numerous speakers, seminars, and symposia throughout the year.

Events

Research Initiatives

Researchers in the CHAL program are involved in a multitude of research initiatives, including:

The “she MATTERS” (iMproving cArdiovascular healTh in new moThERS) project aims to understand if a breastfeeding intervention can improve blood pressure and markers of metabolic risk in women with recent hypertensive disorders of pregnancy (HDP).

she MATTERS

This 10-year study will collect data with the goal of personalizing cardiovascular health care in the future and tailoring treatments to the unique combination of genetic, microbiomic, environmental, and other factors that predispose to heart disease.

Courtois Cardiovascular Signature Program

Contact the CHAL Program

Mohsen Damavandi, PhD

Program Manager

iconEmail

Explore research at the RI-MUHC

Useful links

About the RI-MUHC

The Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and healthcare research centre. The Institute, which is affiliated with the Faculty of Medicine of McGill University, is the research arm of the McGill University Health Centre (MUHC) – an academic health centre located in Montreal, Canada, that has a mandate to focus on complex care within its community. The RI-MUHC supports over 460 researchers and close to 1,200 research trainees devoted to a broad spectrum of fundamental, clinical and health outcomes research at the Glen and the Montreal General Hospital sites of the MUHC.